Journal article
Clinical utility of plasma microbial cell-free DNA sequencing for early diagnosis of toxoplasmosis in high-risk patients: a five-patient case series
- Abstract:
- From 2017 to 2025, we reviewed plasma microbial cell-free DNA sequencing (mcfDNA NGS) results detecting Toxoplasma gondii. Five patients were identified. Median turnaround was 3 days (2–5). mcfDNA initiated therapy in two and supported empiric treatment in three but required clinical context for interpretation.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 125.4KB, Terms of use)
-
- Publisher copy:
- 10.1017/ash.2026.10382
Authors
- Publisher:
- Cambridge University Press
- Journal:
- Antimicrobial Stewardship & Healthcare Epidemiology More from this journal
- Volume:
- 6
- Issue:
- 1
- Article number:
- e134
- Publication date:
- 2026-05-11
- Acceptance date:
- 2026-03-23
- DOI:
- EISSN:
-
2732-494X
- ISSN:
-
2732-494X
- Language:
-
English
- Source identifiers:
-
4031973
- Deposit date:
-
2026-05-11
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2026
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record